Updated Recommendations for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis With Thrombocytopenia Syndrome Among Vaccine Recipients
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
MMWR. Morbidity and Mortality Weekly Report
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Updated Recommendations From the Advisory Committee on Immunization Practices for Use of the Janssen (Johnson & Johnson) COVID-19 Vaccine After Reports of Thrombosis With Thrombocytopenia Syndrome Among Vaccine Recipients — United States, April 2021
MMWR Morb. Mortal. Wkly. Rep. 2021 Apr 30;70(17)651-656, JR MacNeil, JR Su, KR Broder, AY Guh, JW Gargano, M Wallace, SC Hadler, HM Scobie, AE Blain, D Moulia, MF Daley, VV McNally, JR Romero, HK Talbot, GM Lee, BP Bell, SE OliverFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.